ALBRECHT DETLEF (Chief Medical Officer) sold 4.7% of their position (1K shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $22.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/5/2020ACC: 0001567619-20-014306
Officer· Chief Medical Officer
Since Sep 2019
-1K
Net shares
Net seller
$22.9K
Total sold
2
Open market trades
0B · 2S
5
Total transactions
1K acquired · 2K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+800.00
Price / share
$4.56
Trade value
$3.65K
% of position
4.0%
8/3/2020
20.21K→21.01K
Common Stock
Direct
Shares
−800.00
Price / share
$22.85
Trade value
$18.28K
% of position
3.8%
8/3/2020
21.01K→20.21K
Common Stock
Direct
Shares
+200.00
Price / share
$4.56
Trade value
$912.00
% of position
1.0%
8/3/2020
20.21K→20.41K
Common Stock
Direct
Shares
−200.00
Price / share
$23.12
Trade value
$4.62K
% of position
1.0%
8/3/2020
20.41K→20.21K
Total
Net shares
+0.00
Net value
-$18.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2020 | M · Option Exercise | +800.00 | $4.56 | $3.65K | 4.0% | 20.21K | 21.01K |
| Common Stock Direct | 8/3/2020 | S · Sale | −800.00 | $22.85 | $18.28K | 3.8% | 21.01K | 20.21K |
| Common Stock Direct | 8/3/2020 | M · Option Exercise | +200.00 | $4.56 | $912.00 | 1.0% | 20.21K | 20.41K |
| Common Stock Direct | 8/3/2020 | S · Sale | −200.00 | $23.12 | $4.62K | 1.0% | 20.41K | 20.21K |
| Total | +0.00 | -$18.35K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1K shares
Shares
−1K
Strike price
4.56
Held after
68.47K
Exercisable
—
8/3/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1K shares | 8/3/2020 | S · Sale | −1K | 4.56 | — | 68.47K |